Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis.

Dong-Yang XuBing DaiWei TanHong-Wen ZhaoWei WangJian Kang

Published in: Therapeutic advances in respiratory disease (2022)

HFNC is an effective way of providing respiratory support in the treatment of COVID-19 patients. Older age, a higher WBC count, a higher heart rate, and a lower ROX index after the initiation of HFNC are associated with an increased risk of HFNC failure.

Keyphrases

heart rate
heart rate variability
sars cov
blood pressure
randomized controlled trial
systematic review
physical activity
extracorporeal membrane oxygenation
combination therapy
obstructive sleep apnea
chronic rhinosinusitis
respiratory tract